Results 161 to 170 of about 60,074 (286)

Role of dexamethasone dosage in combination with 5-HT3 antagonists for prophylaxis of acute chemotherapy-induced nausea and vomiting [PDF]

, 1999
Karsten Münstedt, H. Müller, E. Blauth-Eckmeyer, K Stenger, Marek Zygmunt, H. Vahrson   +5 more
openalex   +1 more source

A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab

Therapeutics and Clinical Risk Management, 2016
Mary Lou Affronti,1–3 Sarah Woodring,1,2 Katherine B Peters,1,4 James E Herndon II,5 Frances McSherry,5 Patrick N Healy,5 Annick Desjardins,1,4 James J Vredenburgh,6 Henry S Friedman1,2 1The Preston Robert Tisch Brain Tumor Center at Duke ...
Affronti ML, Woodring S, Peters KB, Herndon II JE, McSherry F, Healy PN, Desjardins A, Vredenburgh JJ, Friedman HS   +8 more
doaj  

Palonosetron in the prevention of chemotherapy-induced nausea and vomiting: an evidence-based review of safety, efficacy, and place in therapy

, 2015
Luigi Celio, Monica Niger, Francesca Ricchini, Francesco Agustoni   +3 more
openalex   +2 more sources

PCN96 CANCER PATIENT PREFERENCES AND WILLINGNESS TO PAY FOR PREVENTING CHEMOTHERAPY INDUCED NAUSEA AND VOMITING IN THE UNITED STATES [PDF]

, 2011
Paul J. Miller, S Balu, David A. Buchner, Mark S. Walker, Edward J. Stepanski, L. Schwartzberg   +5 more
openalex   +1 more source

Ginger - mechanism of action in chemotherapy-induced nausea and vomiting: A review [PDF]

, 2017
Wolfgang Marx, Karin Ried, Alexandra McCarthy, Luis Vitetta, Avni Sali, Dan McKavanagh, Elisabeth Isenring   +6 more
openalex  

Pediatric oncology provider perspectives and patient/family perceptions of chemotherapy‐induced nausea and vomiting management: Experiences at an academic medical center [PDF]

Hadley Bloomhardt, Melissa Rubin, Yanling Xue, Zhezhen Jin, Laura Masino, Drew Seidel, Nobuko Hijiya, Melissa Beauchemin   +7 more
openalex   +1 more source

Phase 3 (P04832) Trial Results for Rolapitant, a Novel Nk-1 Receptor Antagonist, in the Prevention of Chemotherapy-Induced Nausea and Vomiting (Cinv) in Patients Receiving Cisplatin-Based Chemotherapy

, 2014
Martin Chasen, Allen Poma, M L Hedley, R. Martell, Cesare Gridelli   +4 more
openalex   +1 more source

A Study to Assess the Effectiveness of Ginger Tea on Reduction of Chemotherapy induced Nausea and Vomiting among the Patients Receiving Chemotherapy in Selected Cancer Hospitals of Bagalkot [PDF]

, 2021
S G Shreeya, Prafulla Kumar D, Deelip S Natekar   +2 more
openalex   +1 more source

PCN48 IMPACT ON HOSPITAL OUTPATIENT VISIT COSTS BY INITIATING PALONOSETRON VERSUS OTHER 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONISTS FOR PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) AMONG PATIENTS WITH CANCER [PDF]

, 2011
Christopher Craver, J. Gayle, S Balu, David A. Buchner   +3 more
openalex   +1 more source

Effectiveness of antiemetic regimens in controlling chemotherapy induced nausea and vomiting during hematopoietic stem cell transplantation. [PDF]

Sci Rep
Suárez-Casillas P, Ciudad-Gutiérrez P, Pérez-Moreno MA, Blázquez-Goñi C, Domínguez FMM, Pérez-Simón JA, Martín LA.   +6 more
europepmc   +1 more source